Last checked at 21 Dec 2020 07:00
Ap19
FORM 8.3 Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 16 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,064,072 | 2.38% | 689,587 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
365,705 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,429,777 | 2.66% | 1,428,592 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 211.9300 USD |
| Purchase | 1 | 212.0300 USD |
| Purchase | 3 | 211.3566 USD |
| Purchase | 7 | 212.7828 USD |
| Purchase | 8 | 212.3462 USD |
| Purchase | 9 | 212.6044 USD |
| Purchase | 26 | 212.4417 USD |
| Purchase | 34 | 212.3200 USD |
| Purchase | 34 | 212.2900 USD |
| Purchase | 38 | 212.4944 USD |
| Purchase | 39 | 212.5900 USD |
| Purchase | 40 | 212.4050 USD |
| Purchase | 41 | 212.5563 USD |
| Purchase | 42 | 212.6440 USD |
| Purchase | 42 | 212.5192 USD |
| Purchase | 45 | 212.4715 USD |
| Purchase | 46 | 212.4126 USD |
| Purchase | 48 | 212.5612 USD |
| Purchase | 54 | 212.6124 USD |
| Purchase | 100 | 211.7600 USD |
| Purchase | 171 | 210.0100 USD |
| Purchase | 175 | 211.6335 USD |
| Purchase | 255 | 212.1229 USD |
| Purchase | 340 | 212.1760 USD |
| Purchase | 406 | 211.9913 USD |
| Purchase | 420 | 212.2917 USD |
| Purchase | 539 | 212.0371 USD |
| Purchase | 660 | 212.2931 USD |
| Purchase | 754 | 212.1561 USD |
| Purchase | 817 | 212.4306 USD |
| Purchase | 825 | 212.0832 USD |
| Purchase | 994 | 212.0950 USD |
| Purchase | 1,202 | 212.0013 USD |
| Purchase | 3,640 | 211.9613 USD |
| Purchase | 3,941 | 212.3610 USD |
| Purchase | 4,186 | 212.2792 USD |
| Purchase | 8,310 | 211.9679 USD |
| Purchase | 11,648 | 212.1026 USD |
| Purchase | 13,166 | 211.9800 USD |
| Purchase | 14,452 | 212.3990 USD |
| Sale | 1 | 211.0000 USD |
| Sale | 2 | 210.4500 USD |
| Sale | 2 | 211.5350 USD |
| Sale | 9 | 212.6044 USD |
| Sale | 34 | 212.2900 USD |
| Sale | 100 | 212.3800 USD |
| Sale | 100 | 212.3500 USD |
| Sale | 102 | 212.0350 USD |
| Sale | 143 | 212.7184 USD |
| Sale | 171 | 210.0100 USD |
| Sale | 744 | 212.3117 USD |
| Sale | 1,051 | 212.5628 USD |
| Sale | 1,632 | 212.1365 USD |
| Sale | 1,818 | 212.2410 USD |
| Sale | 2,898 | 212.2877 USD |
| Sale | 3,640 | 211.9613 USD |
| Sale | 5,471 | 212.0146 USD |
| Sale | 6,486 | 212.1599 USD |
| Sale | 9,908 | 212.1562 USD |
| Sale | 13,506 | 212.4046 USD |
| Sale | 20,966 | 211.9800 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 21 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201220005038/en/
Copyright Business Wire 2020